Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Breast 2Sarcoma 1Plasma cell 1Other hematologic neoplasm 1Lymphoid 1Genitourinary 1

Conditions

Leukemia, Myeloid, Acute 176Leukemia 148Myelodysplastic Syndromes 139Precursor Cell Lymphoblastic Leukemia-Lymphoma 113Lymphoma 80Lymphoma, Non-Hodgkin 73Leukemia, Lymphocytic, Chronic, B-Cell 70Hodgkin Disease 64Congenital Abnormalities 63Leukemia, Myeloid, Chronic-Phase 60Multiple Myeloma 58Myeloproliferative Disorders 54Leukemia, Myelomonocytic, Chronic 53Leukemia, Myeloid, Accelerated Phase 53Lymphoma, Large B-Cell, Diffuse 50Lymphoma, Follicular 50Lymphoma, Mantle-Cell 47Burkitt Lymphoma 46Lymphoma, B-Cell, Marginal Zone 45Leukemia, Myelogenous, Chronic, BCR-ABL Positive 45Blast Crisis 44Lymphoma, Large-Cell, Immunoblastic 43Anemia, Refractory, with Excess of Blasts 43Neoplasms, Plasma Cell 41Hematologic Neoplasms 35Graft vs Host Disease 35Primary Myelofibrosis 33Myelodysplastic-Myeloproliferative Diseases 33Leukemia, Myeloid, Chronic, Atypical, BCR-ABL Negative 32Dendritic Cell Sarcoma, Interdigitating 32

Interventions

liposomal doxorubicin 1flt3 ligand protein 1entinostat 1Watchful Waiting 1Vorinostat 1Thrombopoietin 1Thiotepa 1Therapeutics 1Thalidomide 1Stem Cell Factor 1Radiotherapy 1Psychiatric Rehabilitation 1Peripheral Blood Stem Cell Transplantation 1Melphalan 1Filgrastim 1Fentanyl 1Etoposide 1Docetaxel 1Cyclophosphamide 1Carmustine 1Carboplatin 1Capecitabine 1Busulfan 1Bortezomib 12,2-dimethyl-N-(6-oxo-6,7-dihydro-5H-dibenzo(b,d)azepin-7-yl)-N'-(2,2,3,3,3-pentafluoropropyl)malonamide 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Breast Neoplasms, Male × Busulfan × Other hematologic neoplasm × Clear all
NCT00060255 2013-05-09

High-Dose Chemotherapy, Total-Body Irradiation, and Autologous Stem Cell Transplantation or Bone Marrow Transplantation in Treating Patients With Hematologic Cancer or Solid Tumors

Roswell Park Cancer Institute

Phase 2 Completed
451 enrolled
BreastGenitourinaryLymphoidOther hematologic neoplasmPlasma cellSarcoma

Testicular Germ Cell Tumor, Congenital Abnormalities, Immunoglobulin Light-chain Amyloidosis, Blast Crisis, Breast Neoplasms, Burkitt Lymphoma, Hodgkin Disease, Leukemia, Lymphoma, Lymphoma, Follicular, Lymphoma, Non-Hodgkin, Waldenstrom Macroglobulinemia, Multiple Myeloma, Recurrence, Testicular Neoplasms, Leukemia, Lymphocytic, Chronic, B-Cell, Leukemia, Myeloid, Accelerated Phase, Leukemia, Myeloid, Chronic-Phase, Leukemia, Myeloid, Acute, Lymphoma, Large-Cell, Immunoblastic, Lymphoma, Large B-Cell, Diffuse, Lymphoma, B-Cell, Marginal Zone, Breast Neoplasms, Male, Lymphoma, Mantle-Cell, Neoplasms, Plasma Cell, Leukemia, Myeloid, Chronic, Atypical, BCR-ABL Negative, Dendritic Cell Sarcoma, Interdigitating

Data powered by HemOnc (CC BY 4.0) Colophon âš¡